The role of nitric oxide in cardiac ischemia-reperfusion injury

Japanese Circulation Journal

Volumn 61, Issue 2, 1997, Pages 119-132

  Nonami, Yoshiki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Ischemia Reperfusion Injury; Nitric Oxide

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; C 87 3754; FREE RADICAL; ISOENZYME; LINSIDOMINE; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; SCAVENGER; SPM 5185; UNCLASSIFIED DRUG;

DRUG MECHANISM; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PROTECTION; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE INHIBITION; LEUKOCYTE AGGREGATION; NONHUMAN; PATHOGENESIS; REPERFUSION INJURY; REVIEW; VASODILATATION;

ANIMALS; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0030892444     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.61.119     Document Type: Review

References (69)

1. Furchgott RF, Vanhoutte PO: Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007-2018
2. Jennings RB, Reimer KA, Steenbergen C: Myocardial ischemia revisited: the osmolar load, membrane damage and reperfusion. J Mol Cell Cardiol 1986; 18: 769-780
3. Quillen JE, Selke FW, Brooks LA, Harrison DG: Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 1990; 2: 586-594
4. Johnson G, Tsao PC, Lefer AM: Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991; 19: 244-252
5. Siegfried MR, Erhardt J, Rider T, Ma X-L, Lefer AM: Cardioprotection of organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992; 260: 668-675
6. Lefer DJ, Nakanishi K, Johnson WE, Vinten-Johansen J: Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993; 88: 2337-2350
7. Lefer DJ, Nakanishi K, Vinten-Johansen J: Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 1993; 22: S34-43
8. Weyrich AS, Ma X-L, Lefer AM: The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia m the cat. Circulation 1992; 86: 279-288
9. Nakanishi K, Zhao ZQ, Vinten-Johansen J, Hudspeth DA, McGee DS, Hammon JW Jr, et al: Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 1995; 103: 1146-1154
10. Nakanishi K, Vinten-Johansen J, Lefer DJ, Fowler WC, McGee DS, Johnston WE: Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992; 263: H1650-1658
11. Hiramatsu T, Forbess JM, Miura T, Mayer JE Jr: Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. Evidence for an important role of endothelial production of nitric oxide. J Thorac Cardiovasc Surg 1995; 109: 81-87
12. Sato H, Zhao ZQ McGee D, Williams MW, Hammon JW, Vinten-Johansen J: Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 1995; 110: 302-314
13. Amrani M, Chester AH, Jayakumar J, Schyns CJ, Yacoub MM: L-Arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res 1995; 30: 200-204
14. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, et al: Cardiopulmonary bypass, myocardial management, and support techniques, constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 1995; 110: 1047-1053
15. Wanna FS, Ohayashi DY, Young JN, DeCampli WM: Simultaneous manipulation of the nitric oxide and prostanoid pathways reduces myocardial reperfusion injury. J Thorac Cardiovasc Surg 1995; 110: 1054-1062
16. Fukuda H, Sawa Y, Kadoba K, Taniguchi K, Shimazaki Y, Matsuda H: Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation 1995; 92: 413-416
17. Schulz R, Wambolt R: Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res 1995; 30: 432-439
18. Patel VC, Yellon DM, Singh KJ, Neild GH, Woolfson RG: Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 1993; 194: 234-238
19. Woolfson RG, Patel VC, Neild GH, Yellon DM: Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 1995; 91: 1545-1551
20. Takeuchi K, McGowan FX, Danh H-C, Glynn P, Simplaceanu E, del Nido PJ: Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to myocardium. J Mol Cell Cardiol 1995; 27: 1405-1414
21. G-nitro-L-arginine improves myocardial function following ischemia-reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 1995; 27: 419-426
22. Palmer RMJ, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666
23. DeBelder AJ, Radomski MW, Why HFJ, Richardson PJ, Bucknall CA, Salas E, et al: Nitric oxide synthase activities in human myocardium. Lancet 1993; 341: 84-85
24. Archer S: Measurement of nitric oxide in biological models. FASEB J 1993; 7: 349-360
25. Moncada S: The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992; 145: 201-227
26. Estrada Gomez C, Martin C, Mondada S, Gonzalez C: Nitric oxide mediates tumor necrosis factor-alfa cytotoxicity in endothelial cells. Biochem Biophys Res Commun 1992; 186: 475-482
27. Bogle RG, Baydoun AR, Pearson CD, Moncada S, Mann GE: L-arginine transport is increased in macrophages generating nitric oxide. Biochem J 1992; 284: 15 -18
28. Bogle RG, Moncada S, Pearson CD, Mann GE: Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 1992; 105: 768-770
29. Node K, Kitakaze M, Yokoyama H, Imai K, Komamura K, Minamino T, et al: Evidence for nitric oxide production from human ischemic hearts. J Mol Cell Cardiol 1995; A159
30. Shultz R, Nava E, Moncada S: Induction and potential biological relevance of a calcium-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105: 575-580
31. Shindo T, Ikeda U, Ohkawa F., Kawahara K, Yokoyama M, Shimada K: Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 1995; 29: 813-819
32. Flaherty JT: Nitrate tolerance: A review of the evidence. Drug 1989; 37: 523-550
33. Miller VM, Vanhoutte PM: Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins. J Cardiovasc Pharmacol 1989; 14: S67-S71
34. Gerzer R, Drummer C, Karrenbrock B, Heim JM: Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo. J Cardiovasc Pharmacol 1989; 14: S115-S119
35. Schini VB, Bond R, Cao Y, Illiano S, Junquero DC, Mombouli JV, et al: The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog. J Cardiovasc Pharmacol 1993; 22: S10-S16
36. Palmer RMJ, Ferrige AC, Moncada S: Nitric oxide release accounts for biologic activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
37. Goretski J, Hollocher TC: Trapping of nitric oxide produced during de nitrification by extracellular hemoglobin. J Biol Chem 1988; 263: 2316-2323
38. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-140
39. Furlong B, Henderson AM, Lewis MJ, Smith JA: Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90: 687-692
40. Sneddon JM, Vane JR: Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988; 85: 2800-2804
41. Arnold WP, Mittal CK, Katsuki S, Murad F: Nitric oxide activates guanylate cyclase and increases guanosine 3',5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci 1977; 74: 3203-3207
42. Brady AJB, Warren JB, Poor-Wilson PA, Williams TJ, Harding AS: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265: H176-H182
43. Welsh N, Eizirik DL, Bendtzen K, Sandier S: Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991; 129: 3167-3173
44. James SL, Glaven J: Macrophage cytotoxicity against schistosomula of Schistosoma mansoli involves arginine-dependent production of reactive nitrogen intermediate. J Immunol 1989; 143: 4208-4212
45. Lepoivre M, Flaman JM, Henry Y: Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J Biol Chem 1992; 267: 22994-23000
46. Kiechle FL, Malinski AT: Nitric Oxide Biochemistry, Pathophysiology, Detection. Am J Clin Pathol 1993; 100: 567-575
47. Pearson PJ, Schaff HV, Vanhoutte PM: Acute endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 1990; 67: 385-393
48. Hashimoto K, Pearson PJ, Schaff HV, Cartier R: Endothelial cell dysfunction after ischemic arrest and reperfusion. A possible mechanism of myocardial injury during reflow. J Thorac Cardiovasc Surg 1991; 102: 668-694
49. Pearson PJ, Lin PJ, Schaff HV: Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 103: 1147-1154
50. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624
51. Inauen ME, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR: Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: Role of elastase. Am J Physiol 1990; 28: H925-931
52. Nilsson FN, Miller VM, Vanhoutte PM, McGregor CGA: Methods of cardiac preservation alter the function of the endothelium in porcine coronary arteries. J Thorac Cardiovasc Surg 1991; 102: 923 -930
53. Braunward E, Kloner R: The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149
54. Tsao PS, Aoki N, Lefer DJ, Johnson G, Lefer AM: Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990; 82: 1402-1412
55. Kloner R: No reflow revisited. J Am Coll Cardiol 1989; 14: 1814-1815
56. Thompson J, Hess M: The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 1986; 28: 449-492
57. Ma X-L, Weyrich AS, Lefer DJ, Lefer AN: Diminished basal nitric oxide release after myocardial neutrophil adherence to coronary endothelium. Circ Res 1993; 72: 403-412
58. Ambrosio C, Jacobus W, Mitchell M, Litt M, Decker L: Effects of ATP precursors on ATP levels and free ADP content and functional recovery of postischemic hearts. Am J Physiol 1989; 256: H560-H566
59. Bolli R: Mechanism of myocardial 'stunning'. Circulation 1990; 82: 723-728
60. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14: 157-167
61. Williams MW, Taft CS, Ramnauth S, Zhao Z-Q, Vinten-Johansen J: Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 1995; 30: 79-86
62. Ignarro L: Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol Toxicol 1990; 67: 1-7
63. Pabla R, Buda AJ, Flynn DM, Blesse SA, Shin AM, Curtis MJ, et al: Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 1996; 78: 65-72
64. Beresewicz A, Karwatowska-Prokopczuk E, Lewartowski B, Cedro-Ceremuzynska K: A protective role of nitric oxide in isolated ischaemic/reperfused rat heart. Cardiovasc Res 1995; 30: 1001-1008
65. Matheis G, Sheeman MP, Buckberg GD, Haybean DM, Young HH, Ignarro LJ: Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992; 262: H616-H620
66. Morita K, Sherman NSP, Buckberg GD, Ihnken K, Matheis G, Young HH, et al: Studies of hypoxemic / reperfusion injury: without aortic clamping. Role of the L-argininenitric oxide pathway: The nitric oxide paradox. J Thorac Cardiovasc Surg 1995; 110: 1200-1211
67. Follette DM, Buckberg GD, Mulder DG, Fonkalsrud EW: Deleterious effects of crystalloid hyperkalemic cardioplegic solutions on arterial endothelial cells. Surg Forum 1980; 31: 253-255
68. Nakanishi K, Zhao ZQ, Vinten-Johansen J, Lewis JC, McGee DS, Hammon JW Jr: Coronary artery endothelial dysfunction after ischemia, blood cardioplegia, and reperfusion. Ann Thorac Surg 1994; 58: 191-199
69. Brown JM, Grosso MA, Tarada GJ, Whitman GJ, Ballerjee A, White CW, et al: Endoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat heart. Proc Natl Acad Sci USA 1989; 86: 2516-2520